Indivior Pharmaceuticals (INDV) Intangibles (2021 - 2023)

Indivior Pharmaceuticals' Intangibles history runs 3 years deep, the most recent figure standing at $237.0 million for Q4 2023.

• In Q4 2023, Intangibles rose 238.57% year-over-year to $237.0 million; the TTM figure through Dec 2023 stood at $237.0 million (up 238.57% YoY), while the FY2023 annual figure was $237.0 million, up 238.57% from the prior year.
• Intangibles was $237.0 million for Q4 2023 at Indivior Pharmaceuticals, up from $70.0 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $237.0 million in Q4 2023 to a low of $70.0 million in Q4 2022.
• Historically, Intangibles has averaged $129.7 million across 3 years, with a median of $82.0 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Intangibles fell 14.63% in 2022, then jumped 238.57% in 2023.
• A 3-year view of Intangibles shows it stood at $82.0 million in 2021, then fell by 14.63% to $70.0 million in 2022, then surged by 238.57% to $237.0 million in 2023.
• The last three Intangibles figures came in at $237.0 million (Q4 2023), $70.0 million (Q4 2022), and $82.0 million (Q4 2021), per Business Quant data.